We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACCO icon
1101
Acco Brands
ACCO
$407M
– –
-900
Closed -$8K
ACET icon
1102
Adicet Bio
ACET
$74.7M
– –
-278
Closed -$212K
ACHC icon
1103
Acadia Healthcare
ACHC
$2.94B
– –
-45,803
Closed -$1.34M
ACIW icon
1104
ACI Worldwide
ACIW
$5.42B
– –
-7,559
Closed -$248K
ACRE
1105
Ares Commercial Real Estate
ACRE
$270M
– –
-5,054
Closed -$77K
ADC icon
1106
Agree Realty
ADC
$9.41B
– –
-600
Closed -$42K
ADM icon
1107
Archer Daniels Midland
ADM
$36.9B
– –
-39,546
Closed -$1.7M
ADNT icon
1108
Adient
ADNT
$1.5B
– –
-13,793
Closed -$179K
AER icon
1109
AerCap
AER
$23.8B
– –
-2,400
Closed -$112K
AES icon
1110
AES
AES
$10.5B
– –
-7,600
Closed -$137K
AEYE icon
1111
AudioEye
AEYE
$75M
– –
-6
Closed –
AGI icon
1112
Alamos Gold
AGI
$13.9B
– –
-3,400
Closed -$17K
AIT icon
1113
Applied Industrial Technologies
AIT
$13.3B
– –
-400
Closed -$24K
AIV
1114
Aimco
AIV
$383M
– –
-18,016
Closed -$121K
AKR icon
1115
Acadia Realty Trust
AKR
$2.84B
– –
-700
Closed -$19K
ALB icon
1116
Albemarle
ALB
$15.5B
– –
-45,186
Closed -$3.7M
ALL icon
1117
Allstate
ALL
$67.5B
– –
-3,300
Closed -$311K
ALNT icon
1118
Allient
ALNT
$1.92B
– –
-6,666
Closed -$153K
AM icon
1119
Antero Midstream
AM
$10.1B
– –
-4,600
Closed -$63K
AMAT icon
1120
Applied Materials
AMAT
$428B
– –
-8,698
Closed -$345K
AMBA icon
1121
Ambarella
AMBA
$3.81B
– –
-5
Closed –
OSG
1122
Octave Specialty Group
OSG
$222M
– –
-10
Closed –
AMH icon
1123
American Homes 4 Rent
AMH
$12.5B
– –
-5,600
Closed -$128K
AMG icon
1124
Affiliated Managers Group
AMG
$9.76B
– –
-800
Closed -$86K
AMKR icon
1125
Amkor Technology
AMKR
$13.7B
– –
-48,868
Closed -$417K
43 44
45
46 47

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.